NCT03511625View on ClinicalTrials.gov

The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

February 26, 2020

Study Completion Date

December 3, 2024

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Acthar Injectable Product

Acthar is a non-specific melanocortin receptor agonist

DRUG

Depo medrol

Depo medrol is an anti-inflammatory glucocorticoid

Trial Locations (1)

90211

Attune Health, Beverly Hills

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Attune Health Research, Inc.

INDUSTRY